Tectonic Therapeutic, Inc.
TECX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $17 | $17 | $13 | $9 |
| G&A Expenses | $5 | $5 | $5 | $5 |
| SG&A Expenses | $5 | $5 | $5 | $5 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $22 | $22 | $18 | $14 |
| Operating Income | -$22 | -$22 | -$18 | -$14 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $3 | $3 | $2 | $2 |
| Pre-Tax Income | -$19 | -$19 | -$16 | -$12 |
| Tax Expense | $0 | $1 | $0 | $0 |
| Net Income | -$19 | -$20 | -$16 | -$12 |
| % Margin | – | – | – | – |
| EPS | -1.02 | -1.07 | -0.93 | -0.84 |
| % Growth | 4.7% | -15.1% | -10.7% | – |
| EPS Diluted | -1.02 | -1.07 | -0.93 | -0.84 |
| Weighted Avg Shares Out | 19 | 19 | 17 | 15 |
| Weighted Avg Shares Out Dil | 19 | 19 | 17 | 15 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3 | $3 | $2 | $2 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $1 |
| EBITDA | -$19 | -$19 | -$16 | -$12 |
| % Margin | – | – | – | – |